2Pignone M. Cost-effectiveness of screening for colorectal cancer: The dollar is in the details[J]. Gastroentroenterol, 2003,124 : 856.
3Niv Y, Lev EM, Fraser G. Protective effect of fecal occult blood test screening for coloreetal cancer: Worse prognosis for screening refusers [J]. Gut, 2002,50 : 33-37.
7Winawer S,Fletcher R,Rex D,Bond J,Burt R,Ferrucci J,Ganiats T,Levin T,Woolf S,Johnson D,Kirk L,Litin S,Simmang C;Gastrointestinal Consortium Panel.Colorectal cancer screening and surveillance:clinical guidelines and rationale-update based on new evidence.
8Bretthauer M,Gondal G,Larsen K,Carlsen E,Eide TJ,Grotmol T,Skovlund E,Tveit KM,Vatn MH,Hoff G.Design,organization and management of a controlled population screening study for detection of colorectal neoplasia:attendance rates in the NORCCAP study (Norweg
9Petersen VC,Baxter KJ,Love SB,Shepherd NA.Identification of objective pathological prognostic determinants and models of prognosis in Dukes'B colon cancer.Gut,2002,51:65-69.
10Lewis JD.Cost-effectiveness of screening for colorectal cancer:the dollar is in the details.Gastroenterology,2003,124:856-858.
